NCT07814703

Brief Summary

Comparison Between Ultrasound-guided Intercostobrachial Nerve Block with Supraclavicular Block versus Ultrasound -guided Erector Spinae block with Supraclavicular Block for Medial Arm A-V Fistula Surgery

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
158

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Apr 2026Jun 2027

Study Start

First participant enrolled

April 1, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

September 11, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 6, 2026

Last Update Submit

September 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • achievement of complete sensory block

    pinprick test showed that the entire upper arm and lateral aspect of the left upper chest wall are anesthetized

    20 minutes after the completion of the nerve blocks

Study Arms (2)

intercostobrachial nerve block

ACTIVE COMPARATOR
Procedure: intercostobrachial nerve block

ultrasound-guided erector spinae plane block

ACTIVE COMPARATOR
Procedure: ultrasound-guided erector spinae plane block

Interventions

the intercostobrachial nerve will be blocked using Ultrasound-Guided Procedure after SCPB, the ICBN was blocked under US guidance at the mid-axillary level. The patient was positioned supine with the arm abducted to 90°. A high-frequency linear probe will be placed transversely over the mid-axillary line at the level of the 2nd-3rd intercostal spaces. The axillary vein and artery were first visualized, then the probe was adjusted superficially to identify the fascial plane between the subcutaneous tissue and the serratus anterior muscle. The ICBN appeared as a small hyperechoic oval or linear structure within this plane. Using an in-plane, posterio-anterior needle approach, an 80-mm block needle was advanced into the fascial plane. After confirming negative aspiration, 10 ml of the same local anesthetic mixture was administered (0.5% bupivacaine and 2% lidocaine)

intercostobrachial nerve block

patient will be placed in a lateral decubitus with the operation site up and we will count the vertebrae from cephalad to caudal direction until we reach T2 spinous process as the first palpable spinous process is C7. Ultrasound probe will be placed vertically 3 cm lateral to the T2 spinous process. linear transducer was placed on the superior-posterior aspect of the operation site shoulder close to the neck to observe the short axis view of the transverse processes of T2 and T3. The same type of block needle was inserted and advanced in a caudad-to-cephalad direction toward the space between the two transverse processes using in-plane ultrasound guidance. Immediately after penetrating the anterior fascia of the erector spinae muscles, 10 ml of the same local anesthetic mixture was administered

ultrasound-guided erector spinae plane block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ESRD patient undergoing creation AVF in the medial side of the arm.

You may not qualify if:

  • \. Patient refusal 2. Drug allergies 3. Body Mass Index of 35 kg/m² or more 4. Coagulation abnormalities 5. Severe heart, kidney, and liver diseases, 6. Pregnancy 7. Vasculitis 8. Unstable hemodynamics 9. Upper extremity neuropathy 10. Mental illness 11. Seizures 12. Contralateral chest problems 13. Infection at site of injection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fayoum University hospital

Al Fayyum, Madīnat Al Fayyūm, Faiyum Governorate, 4312, Egypt

RECRUITING

Study Officials

  • mohamed ahmed Ismail, professor

    Faculty of medicine,Fayoum University

    STUDY CHAIR

Central Study Contacts

taghreed shabaan korany, assistant lecturer

CONTACT

Amr hamdy Mahmoud, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

September 6, 2026

First Posted

September 11, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

September 11, 2026

Record last verified: 2026-09

Locations